The American Society of Clinical Oncology (ASCO) has reviewed complications associated with immune checkpoint inhibitor therapy.
Patient selection: polymyalgia following therapy with an immune checkpoint inhibitor
Parameters:
(1) muscle pain and stiffness
(2) activities of daily living (ADL)
|
Muscle Pain and Stiffness
|
Activities of Daily Living
|
Grade
|
|
mild
|
normal
|
G1
|
|
moderate
|
limited age-appropriate ADL
|
G2
|
|
severe
|
limited self-care ADL
|
G3/G4
|
The diagnosis requires exclusion of other causes of polymyalgia.
Rarely patients may develop giant cell arteritis.
